NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-217-2015-0-US-06 Fluorescent Nanodiamonds As Fiducial Markers For Microscopy And Fluorescence Imaging US National Stage 15/780,388 Abandoned
NIBIB E-062-2017-0-EP-04 Systems and Methods for Three-Dimensional Fluorescence Polarization Via Multiview Imaging EP National Stage 18810466.5 Pending
NIBIB E-062-2017-0-IL-05 Systems and Methods for Three-Dimensional Fluorescence Polarization Via Multiview Imaging IL National Stage 2042-10-27 Pending
NIDCR E-152-2017-0-IL-04 FORMATION OF STABLE CARTILAGE IL National Stage 1991-08-27 Issued
NHGRI E-110-2017-0-PCT-02 Methods of Detecting and Treating GATM-Related Renal Disorders PCT PCT PCT/US2018/035423 Expired
NCATS E-299-2012-0-US-07 BMP Inhibitors and Methods of Use Thereof US CON 15/994,604 Abandoned
NIAID E-103-2014-3-AU-09 Antibody Evolution Immunogens AU DIV 2018203805 Abandoned
NIAID E-042-2018-0-JP-06 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE JP National Stage 2019-565890 Issued
NIAID E-042-2018-0-CN-04 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE CN National Stage 201880048358.8 Pending
NIAID E-042-2018-0-EP-05 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE EP National Stage 18733056.8 Pending
NIAID E-067-2016-3-EP-02 A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation EP National Stage 16794904.9 Pending
NIAID E-042-2018-0-JP-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE JP DIV 2023-063846 Pending
NIAID E-042-2018-0-CA-03 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE CA National Stage 3064267 Pending
NIAID E-042-2018-0-PCT-02 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE PCT PCT PCT/US2018/034848 Expired
NCATS E-004-2016-0-US-08 Substituted Bicyclic Heteroaryl Inhibitors Of Bromodomain-containing Protein BRD4 US National Stage 15/779,353 10508106 Issued PDF
NIAID E-202-2008-0-US-18 INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS US DIV 15/984,956 10881669 Issued PDF
NCI E-213-2014-0-US-06 Methodology For Astatination And Radioiodination Based On Iodonium Salt Precursors US National Stage 15/777,828 10703708 Issued PDF
NCATS E-257-2010-0-US-19 SUBSTITUTED PYRAZOLOPYRIMIDINES AS GLUCOCEREBROSIDASE ACTIVATORS US DIV 15/983,844 10925874 Issued PDF
NCI E-285-2016-2-EP-04 Glypican 2 As A Cancer Marker And Therapeutic Target EP National Stage 16864859.0 Pending
NIAID E-136-2013-0-US-06 Single-Domain VHH Antibodies Directed to Norovirus GI.1 And GII.4 And Their Use US DIV 15/982,998 10662238 Issued PDF
NCI E-106-2017-0-PCT-02 ANTI-MESOTHELIN POLYPEPTIDES AND PROTEINS PCT PCT PCT/US2018/033236 Expired
NCI E-099-2014-0-US-09 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND METHODS OF MAKING THEM US CON 15/981,142 10538588 Issued PDF
CC E-158-2017-0-PCT-02 SYSTEMS, METHODS, AND DEVICES FOR ASSISTING OR PERFORMING
GUIDED INTERVENTIONAL PROCEDURES USING INERTIAL MEASUREMENT
UNITS AND MAGNETOMETER SENSORS 		PCT PCT PCT/US2018/033025 Expired
NCI E-017-2017-0-CN-05 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES CN National Stage 201880032676.5 Issued
NCI E-017-2017-0-EP-06 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES EP National Stage 18733012.1 Abandoned
NCI E-017-2017-0-CA-04 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES CA National Stage 3062433 Pending
NCI E-017-2017-0-PCT-02 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES PCT PCT PCT/US2018/032809 Expired
NCI E-001-2016-0-KR-13 Anti-CD30 Chimeric Antigen Receptors KR National Stage 2018-7013573 Abandoned
NIDCR E-485-2013-2-US-02 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS US ORD 15/979,105 Abandoned
NCI E-010-2016-2-JP-07 Anti-BCMA Polypeptides and Proteins JP National Stage 2018-544769 Issued
NCI E-186-2015-0-US-02 PEPTIDE AND PEPTIDE MIMETIC BINDING ANTAGONISTS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE US ORD 15/977,768 10905769 Issued PDF
NCI E-010-2016-2-EP-05 Anti-BCMA Polypeptides and Proteins EP National Stage 16798612.4 Abandoned
NCI E-010-2016-2-CN-04 Anti-BCMA Polypeptides and Proteins CN National Stage 201680065438.5 Issued
NIAID E-051-2012-3-CN-10 Neutralizing Antibodies To HIV-1 and Their Use CN DIV 201810445511.2 Issued
NCI E-139-2015-0-US-04 FIXATIVES AND METHODS OF USE US National Stage 15/774,480 11313772 Issued PDF
NCI E-065-2017-0-PCT-02 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY PCT PCT PCT/US2018/031618 Expired
NCI E-065-2017-0-EP-05 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY EP National Stage 18727536.7 Abandoned
NCI E-285-2016-2-JP-05 Glypican 2 As A Cancer Marker And Therapeutic Target JP National Stage 2018-543286 Pending
NCI E-127-2017-0-CA-04 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies CA National Stage 3063087 Pending
NCI E-065-2017-0-CA-04 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY CA National Stage 3059472 Pending
NCI E-127-2017-0-PCT-02 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies PCT PCT PCT/US2018/031501 Expired
NCI E-065-2017-0-AU-03 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY AU National Stage 2018268970 Pending
NCI E-291-2012-0-RU-13 M971 Chimeric Antigen Receptors RU DIV 2018116582 Issued
NICHD E-209-2021-0-US-02 Kits And Methods To Distinguish False Labor And True Labor US National Stage 15/773,980 11204354 Issued PDF
NCI E-069-2017-0-EP-04 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL EP National Stage 18727506.0 Issued
NCI E-069-2017-0-FR-07 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL FR EP 18727506.0 Issued
NCI E-069-2017-0-DE-06 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL DE EP 18727506.0 Issued
NCI E-069-2017-0-GB-08 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL GB EP 18727506.0 Issued
NCI E-069-2017-0-CH-05 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL CH EP 18727506.0 Issued
NCI E-010-2016-2-US-09 ANTI-BCMA POLYPEPTIDES AND PROTEINS US National Stage 15/773,687 10925969 Issued PDF